Search Results (509)

Biofilm formation constitutes a major factor in antibiotic treatment failure, shielding bacteria from drugs and promoting persistence. This study demonstrates that the anti-biofilm action of clove oil enhances the efficacy of fosfomycin against Escherichia coli O157:H7 (E. coli O157). Using a luxS-eGFP reporter system, it was found that clove oil inhibited E. coli O157 biofilm formation by up to 80% via suppression of the LuxS/AI-2 quorum sensing (QS) system and bacterial motility. Crucially, this disruption was shown to correlate with a strong synergistic effect when combined with fosfomycin in vitro. In a murine peritoneal infection model, the combination therapy demonstrated superior efficacy compared to monotherapy. Specifically, bacterial loads in the liver, spleen, and small intestine were significantly reduced, and histopathological damage was alleviated. Mechanistically, these effects were linked to the downregulation of the QS. These findings indicate that clove oil acts as a potent adjuvant to fosfomycin by disrupting biofilms, offering a promising strategy against systemic infections caused by E. coli O157. Full article

In intensive animal production, the overuse of antibiotics has exacerbated bacterial antimicrobial resistance and environmental pollution. Together with gut microbiota dysbiosis and recurrent disease outbreaks, these challenges severely constrain the sector’s high-quality development. Quorum sensing (QS), a cell-density-dependent bacterial communication mechanism, can be modulated through agents that specifically inhibit or activate QS circuitry to regulate microbial community functions. Such QS modulators possess notable advantages, such as environmental benignity and high target specificity, and thus offer innovative strategies to decrease antibiotic reliance, enhance production efficiency, and reduce environmental emissions. This review examines QS modulators sourced from plants, microorganisms, animals, and synthetic processes, while highlighting key challenges such as environmental interference, resistance development, high costs, and the lack of standardized biosafety evaluations. Future research should focus on enhancing specificity, stability, affordability, and safety, with an emphasis on rational design, synergistic systems, improved manufacturing processes, and multi-target modulators. This review may provide a theoretical basis for translating QS-regulation technologies into farm-level applications, thereby advancing sustainable animal production and antibiotic-free husbandry. Full article

Pseudomonas fluorescens is a major psychrotrophic bacterium responsible for spoilage in refrigerated foods, particularly dairy products, where deterioration is driven by biofilm formation, quorum sensing (QS) regulation, and the secretion of thermostable lipases. Conventional control strategies reduce bacterial loads but often fail to prevent enzymatic spoilage. Plant-derived phenolic compounds have been widely reported as QS inhibitors and lipase modulators in various biological systems; however, evidence specifically addressing their effects on P. fluorescens regulatory networks and bacterial lipases remains limited. This review critically examines current knowledge on QS-mediated biofilm formation and lipase production in P. fluorescens and analyzes the reported inhibitory activity of phenolic compounds, with emphasis on oak (Quercus spp.)-derived metabolites. While flavonoids and phenolic acids such as quercetin, gallic acid, and p-coumaric acid have demonstrated QS inhibition and antilipolytic activity in other Pseudomonas species and pancreatic models, direct mechanistic validation in P. fluorescens lipases is scarce. Moreover, most studies rely on crude plant extracts without comprehensive metabolomic characterization, and the potential contribution of additional oak metabolites, including terpenoids, remains largely unexplored. Identifying these gaps is essential for advancing toward integrative approaches that combine enzymology, molecular modeling, and validation in food-relevant systems. Full article

The emergence of antibiotic resistance in aquaculture not only makes antibiotic treatments ineffective in aquaculture but also poses a threat to public health. In order to overcome this, novel strategies to control bacterial diseases are needed. Antivirulence therapy, which disrupts virulence without affecting bacterial viability, represents a promising alternative approach. This study evaluated the antivirulence activity of Qstatin against pathogenic vibrios belonging to the Harveyi clade. Qstatin specifically inhibited the three-channel quorum sensing system in Vibrio campbellii, significantly downregulated the expression of quorum sensing-regulated virulence genes (flaA, flaK, vpsR, vpsT, and vhp) and attenuated the corresponding phenotypes: swimming motility was reduced by up to 57% and biofilm formation by up to 76%. Protease activity, in contrast, was slightly increased rather than decreased. Finally, treatment with 100 μM Qstatin significantly increased the survival of gnotobiotic brine shrimp larvae upon challenge with each of 13 tested pathogenic Harveyi clade strains (belonging to the species V. campbellii, V. harveyi, or V. parahaemolyticus), without an impact on Vibrio densities in the rearing water. These findings indicate that Qstatin has a broad-spectrum antivirulence activity against Harveyi clade vibrios by inhibiting quorum sensing, thus supporting its potential as a sustainable disease control agent. Full article

Natural and artificial marine surfaces are rapidly colonized by microscopic communities, including propagules of some macrofoulers, in a process called biofouling. These microbiomes play an important role in modulating the evolving microbial community, as well as the attachment and settlement of other invertebrate larvae. Microbiomes act as biochemical and biophysical interfaces in marine communities. This review explores the gene-level processes that underlie microbial functions relevant to biofouling and larval settlement, such as quorum sensing, extracellular polymeric substance (EPS), and innate immune system components, as well as biosynthetic and degradative processes that generate signaling molecules. We critically evaluate current knowledge on how microbial metabolites promote or inhibit larval recruitment in corals, barnacles, polychaetes, and bivalves, and how omics-based approaches are uncovering the functional potential of biofilm communities. We evaluate how these interactions influence ecosystem services, such as habitat structuring, reef resilience, and coastal infrastructure maintenance. Full article

Chronic wounds, diabetic foot ulcers, venous leg ulcers, and pressure injuries affect millions of patients worldwide and cost healthcare systems in the order of $150 billion annually, yet treatment options have changed less than the scale of the problem would suggest. Biofilm formation, documented in up to 78% of chronic wounds, is a central cause: bacteria embedded in extracellular polymeric matrices tolerate antimicrobial concentrations up to 1000-fold higher than planktonic cells and sustain a chronic inflammatory state that actively prevents tissue repair. Hydrogels, crosslinked polymer networks with high water content and tunable physicochemical properties, have been widely studied as platforms for addressing these challenges, though the distance between laboratory results and clinical practice remains considerable. While recent reviews have summarized hydrogel materials or antimicrobial strategies in isolation, this review takes a different approach: we treat infection, biofilm persistence, and impaired regeneration as interconnected processes that must be addressed simultaneously, and we examine biofilm management as a distinct therapeutic target rather than merely a subset of antimicrobial delivery. We analyze hydrogel-based wound care across three integrated domains: design principles (natural, synthetic, and hybrid polymer systems; crosslinking strategies; and stimuli-responsive architectures), antimicrobial delivery (silver, antibiotics, antimicrobial peptides, natural agents, and controlled-release systems), and biofilm management (nanoparticle-mediated disruption, enzymatic EPS degradation, photodynamic approaches, quorum-sensing inhibition, and anti-adhesive surface engineering). For each area, we critically evaluate what the preclinical evidence supports, where it falls short, and what would be needed to bridge the gap to clinical application. Translation remains uneven. Among the many FDA- and EMA-cleared hydrogel dressings currently in clinical use, most are simple moisture-retaining or silver-containing formulations, while the multifunctional systems that dominate the research literature are at earlier stages of development. We discuss the main translational priorities, including more predictive preclinical models, long-term nanomaterial safety, harmonized outcome reporting, manufacturing scalability, and health economic evidence, as areas where further work can meaningfully accelerate clinical adoption. Full article

Antimicrobial resistance (AMR) represents a major global health threat, largely driven by antibiotic overuse and the protective role of bacterial biofilms. Quorum sensing (QS), a bacterial communication system regulating virulence and biofilm formation, has emerged as a promising therapeutic target. Quorum quenching (QQ), which disrupts QS without directly inhibiting bacterial growth, is considered a potential anti-virulence strategy that may reduce selective pressure for resistance. This review critically evaluates recent advances in QQ research, focusing on its clinical applicability, limitations, and risks. We analyzed studies from the last five years involving natural compounds, synthetic molecules, nanoparticles (NPs), and combination therapies targeting key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus in models of lung diseases, mainly cystic fibrosis, chronic wounds, burns, and implant-associated infections. While numerous compounds demonstrate significant in vitro anti-biofilm and anti-virulence activity, major challenges remain, including limited in vivo validation, pharmacokinetic constraints, toxicity concerns, microbiome disruption, and the potential development of tolerance or functional resistance. Although QQ offers a promising adjunctive approach to conventional antibiotics, its long-term clinical feasibility requires comprehensive evaluation of evolutionary dynamics, host–microbe interactions, and safety profiles. Full article

Quorum Quenching (QQ) is a mechanism that disrupts Quorum Sensing (QS) signaling systems, which regulate gene expression based on bacterial population density. Many fish pathogens, such as Aeromonas, utilize QS systems to regulate the expression of their virulence factors. Disrupting these systems using QQ is a promising approach for infection control in aquaculture and may provide a safe alternative to antibiotics. Therefore, identifying microorganisms with QQ activity is a relevant task in agricultural microbiology and veterinary medicine. This study examines the identification of isolates with QQ activity in the microbial community of perch and assesses their probiotic potential for the prevention of aeromonosis. In this study, we isolated 32 strains of microorganisms capable of degrading N-acylhomoserine lactone (AHL), six of which exhibited stable QQ activity. Five strains were found to belong to the genus Rhodococcus, and one strain to the genus Exiguobacterium. The selected strains were tested for the enzymatic/non-enzymatic and intra-/extracellular QQ activity, pathogen growth inhibition, biofilm formation, and hemolytic activity, as well as growth ability under various environmental conditions (salinity, pH, bile acids, and temperature). Based on the results of these tests, the R. erythropolis PFS1.20 strain was selected as the most promising probiotic. The genomic analysis revealed that the studied strain contains genes encoding QQ enzymes, siderophore biosynthesis clusters, osmoprotectors, and compounds with antimicrobial properties. These results indicate the high probiotic potential of the R. erythropolis PFS1.20. Full article

Acinetobacter baumannii, a prominent opportunistic pathogen in healthcare settings, causes severe infections and poses significant challenges for clinical treatment. This study investigates the synergistic effects of α-pinene combined with meropenem (MEM) on A. baumannii biofilm formation and lung injury in mice, aiming to develop new strategies to combat persistent infections and antibiotic resistance. α-pinene combined with MEM exhibited strong synergistic antibacterial activity against carbapenem-resistant A. baumannii (CRAB 5E9). The combination significantly inhibited biofilm formation, extracellular polymer production, surface motility, and quorum sensing. The expression of key genes such as ompA, bfmR, bap, csuAB, abaI, and abaR was reduced by up to 61%. In vivo, the treatment alleviated weight loss, decreased the bacterial load in lung tissue, and reduced lung inflammation. Furthermore, it significantly suppressed proteins involved in the inflammatory response and the MAPK pathway, including TLR4, NF-κB, NLRP3, TRAF6, ERK2, p38 MAPK, JNK, and TNF-α. The combination of α-pinene and MEM synergistically inhibits A. baumannii biofilm formation and alleviates the inflammatory response in a mouse model, offering a potential therapeutic approach for combating A. baumannii infections. Full article

Propolis is a bee product with a complex chemical composition that exhibits remarkable antifungal activity against C. albicans and can inhibit resistant biofilms thanks to its content of compounds such as flavonoids and phenolic acids. Its efficacy varies depending on its geographic origin: European propolis inhibits the initial formation of biofilms, while Brazilian propolis is superior at inhibiting mature biofilms. This product also possesses fungicidal and fungistatic properties comparable in efficacy to conventional drugs, such as nystatin, fluconazole, and chlorhexidine. The use of nanotechnology, such as nanoparticles or nanorods, has overcome the low solubility of propolis compounds, improving their bioavailability and reducing cell adhesion and hyphal formation. Moreover, the integration of propolis into dental materials demonstrate its versatility for preventing recurrent infections. The study of isolated compounds such as pinocembrin, galangin, and chrysin has facilitated the identification of specific mechanisms of action, and the application of molecules such as guttiferone E in photodynamic therapies and the discovery of quorum-sensing inhibitors, such as kaempferol, using in silico models have opened new avenues for blocking yeast communication and virulence. These findings position propolis as a multifaceted and promising therapeutic alternative, although there is a need to optimize formulations to ensure clinical safety and biocompatibility. In this review, we analyze research published around the world over the last 15 years on the effects of propolis against C. albicans biofilms. Full article

This study assessed the impact of a topical phytocomplex on the acne skin microbiota, encompassing bacterial, fungal, and phage communities. Skin samples obtained from participants exhibiting a positive response to the treatment were analyzed using high-throughput sequencing and bioinformatic approaches including taxonomic profiling, metagenome assembly, functional annotation, and phage identification. Results showed that after treatment, microbial diversity increased, reflecting a more balanced microbial composition. Cutibacterium acnes levels were reduced, particularly virulent IA1/IA2 phylotypes, whereas non-pathogenic or unclassified strains increased. Opportunistic pathogens such as Klebsiella pneumoniae were no longer detected, and beneficial genera including Psychrobacter and Dermabacter were enriched. Functional analysis showed reduced virulence- and biofilm-related pathways, alongside enhanced tryptophan metabolism, SCFA production, lipid synthesis, and riboflavin and folate biosynthesis. Fungal populations, dominated by Malassezia, became more evenly distributed, with notable post-treatment reductions in M. arunalokei, Exophiala spinifera, and Wickerhamomyces anomalus. Phage populations mirrored bacterial changes, with enrichment of Cutibacterium-associated phages post-treatment. These findings demonstrate that the phytocomplex promotes functional rebalancing of the skin microbiota by reducing pathogenic features while maintaining ecosystem stability. The inhibition of quorum sensing, potentially mediated by N-acyl-homoserine lactone acetylation, emerged from metabolic pathway annotation as a hypothetic key mechanism impairing bacterial communication and virulence associated with acne vulgaris. Full article

Baicalin, a natural plant-derived compound, holds promise in addressing clinical bacterial resistance when combined with antibiotics. This study evaluated the antibacterial activity of the combination of baicalin and cefotaxime and explored its mechanism of action on the cell wall and biofilm of multidrug-resistant Pseudomonas aeruginosa (MRPA). The results showed that the combination of baicalin and cefotaxime exerted a synergistic inhibitory effect on the growth of MRPA, with a fractional inhibitory concentration index (FICI) of 0.28. Mechanistically, compared with cefotaxime alone, the combination of baicalin and cefotaxime enhanced the permeability of the cell membrane and cell wall of MRPA, thereby increasing cell damage. It also exhibited stronger antibiofilm activity by inhibiting numerous virulence factors (pyocyanin, elastase, lectin), reducing cellular metabolic activity, and downregulating the expression of biofilm genes (pslA, pelA, algD) and quorum-sensing genes (lasl, lasR, rhll, rhlR, pqsA, pqsR). The molecular docking results revealed that baicalin could stably bind to wbpE, LasR, and RhlR. Therefore, this interaction may indirectly influence the processes related to antibiotic resistance and biofilm formation in bacterial cells. Metabolomic analysis revealed that the combination of baicalin and cefotaxime upregulated 863 metabolites and downregulated 587 metabolites. These metabolites mainly included amino acids, lipids, nucleotides, carbohydrates, and secondary metabolites. The combination primarily enriched key pathways such as amino acid metabolism, lipid metabolism (sphingolipid metabolism) and secondary metabolite biosynthesis. Through these pathways, it triggers significant metabolic reprogramming, thereby interfering with the supply of cell wall synthesis precursors, membrane structural stability, and the generation of biomembrane matrix. Ultimately, it synergistically enhances the effects of cell wall damage and biomembrane inhibition. In conclusion, this study confirms that the combination of baicalin and cefotaxime exerts significant synergistic antibacterial activity against MRPA. It also reveals the mechanism of action of the combination on the cell wall and biofilm of MRPA at the metabolic level, providing theoretical support for the development of novel strategies to combat MRPA. Full article

Allium longistylum is a relatively understudied species whose phytochemical composition and biological activities remain largely unexplored. In this study, the first true leaf (FTL) and the second true leaf (STL) of A. longistylum were compared with respect to phenolic composition, antioxidant capacity, antimicrobial activity, and quorum-sensing (QS) inhibition. Total phenolic content (TPC) and total flavonoid content (TFC) were determined spectrophotometrically, while antioxidant activity was evaluated using ABTS and DPPH radical scavenging assays. Antimicrobial and anti-QS activities were assessed against Staphylococcus aureus, Acinetobacter baumannii, and Chromobacterium violaceum. STL exhibited significantly higher TPC and TFC than FTL, consistent with its stronger radical scavenging activity. Both extracts showed moderate antimicrobial activity and reduced violacein production in C. violaceum, indicating interference with QS. UPLC-Q-Orbitrap-ESI-MS/MS profiling tentatively identified several phenolic acids and flavonoid derivatives. HPLC analysis confirmed the presence of selected phenolic compounds, although several prominent peaks in the chromatograms remained unidentified. Many of the compounds detected by UPLC-Q-Orbitrap-ESI-MS/MS and HPLC have previously been reported to exhibit antioxidant, antimicrobial, and anti-QS activities; their presence may therefore contribute to the bioactivities observed in both extracts. However, their contribution to the observed effects remains speculative and requires further validation through targeted isolation and bioactivity testing. The results suggest that A. longistylum is a promising source of phenolic compounds with antioxidant and antimicrobial properties. Full article

Background/Objectives: Cyanobacteria represent a diverse group of microorganisms capable of synthesizing a broad array of biologically active metabolites. Some of these compounds, believed to contribute to the ecological and evolutionary success of cyanobacteria, are increasingly being investigated for potential biomedical and biotechnological applications. They also hold promise in combating the growing threat of antimicrobial resistance (AMR). This screening study aimed to identify Baltic cyanobacterial strains with the potential to produce antibacterial compounds active against streptococci and mycobacteria, as well as quorum sensing inhibitors. Methods/Results: Extracts from forty-four cyanobacterial strains were tested using a broth microdilution assay. The most pronounced activity was observed for extracts derived from two Pseudanabaenaceae strains (KUCC C3 and C4), two Anabaena spp. strains (CCNP 1405 and CCNP 1406), and Aphanizomenon sp. KUCC C1. Inhibition of quorum sensing was the most frequently detected activity, with 30% of the tested extracts inhibiting violacein production in Chromobacterium violaceum ATCC 12472. Growth inhibition of Gram-positive bacteria was less common: 16% of cyanobacterial strains inhibited Streptococcus pyogenes ATCC 12344, and 11% inhibited Mycobacterium smegmatis ATCC 14468. Bioassay-guided fractionation of Aphanizomenon sp. KUCC C1, followed by LC–MS/MS analysis, revealed the presence of glycerolipids and glycolipids, including diacylglycerols (DAGs) and galactosyldiacylglycerols (MGDGs and DGDGs), as major constituents of fractions exhibiting quorum quenching activity. Conclusions: These findings highlight the potential of Baltic cyanobacteria as a source of natural compounds capable of disrupting bacterial communication and growth, offering prospects for the development of novel antimicrobial and anti-virulence agents. Full article

Due to increasing antimicrobial resistance and oxidative stress, the exploration of new therapeutic agents from medicinal plants such as Galium aparine L., has become essential. This study aimed to provide a scientific basis for the ethnomedicinal applications of G. aparine by evaluating its biological activities and biochemical composition. Plant samples were extracted using different solvents and their biological activities were assessed through antimicrobial, antibiofilm, and anti-quorum sensing (AQS) assays against different microorganisms. Antioxidant capacity was determined using four complementary assays representing distinct mechanisms, while the biochemical composition was analyzed via GC–MS. The results revealed that although the extracts exhibited limited antimicrobial activity overall, significant inhibition was observed against Staphylococcus aureus, and Enterococcus strains, with MIC values as low as 30 µg/mL. The ethanol extract demonstrated the highest antibiofilm inhibition (60.38%) against Streptococcus mutans, surpassing the positive control Halamid, and showed the strongest AQS inhibition (46.16%). Moreover, a strong antioxidant potential comparable to ascorbic acid was detected in the ABTS assay, with 88.10% inhibition. Overall, these findings indicate that G. aparine extracts possess notable antibiofilm, AQS, and antioxidant properties that support their traditional medicinal uses and suggest their potential as promising sources for the development of new natural therapeutic agents. Full article